Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapy. [electronic resource]
Producer: 20190726Description: 155-161 p. digitalISSN:- 1469-0756
- Adult
- Aged
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- diagnostic imaging
- Chemotherapy, Adjuvant
- Female
- Hong Kong
- Humans
- Lapatinib -- administration & dosage
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Recurrence, Local -- pathology
- Neoplasm Staging
- Receptor, ErbB-2
- Retrospective Studies
- Survival Rate
- Trastuzumab -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.